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Abstract OBJECTIVES: In the present paper the circadian variation and age differences in 
human leukocyte reactive oxygen species (ROS) levels and plasma total anti-
oxidant status were studied. Different ROS levels could influence disease during 
ageing and at different times of the day/night.
METHODS: Unstimulated and stimulated (12-O-tetradecanoyl-phorbol-13-acetate 
(TPA)) blood samples were analysed by flow cytometry using dihydroethidium 
(DHE) and dihydrorhodamine 123 (DHR) as probes. 60 healthy individuals were 
divided into five equal groups ((I) 1–2 days post partum, (II) 20 ± 2 years, (III) 40 
± 2 years, (IV) 60 ± 2 years and (V) 80 ± 2 years) and 6 healthy volunteers were 
followed with blood samples at 3 hour intervals for 24 hours.
RESULTS: We observed a significant peak of ROS levels in both monocytes and 
granulocytes at 6 pm and 3 am using DHE as probe. DHR showed in principle 
the same pattern. The monocytes (unstimulated and stimulated) and unstimu-
lated granulocytes of the newborn group showed higher ROS values than all the 
other groups, whereas the groups of adults did not differ from each other. The 
plasma total antioxidant status was significantly higher in the newborn group 
and showed no circadian variation.
CONCLUSIONS: The present data show that there is a circadian variation of ROS 
production in leukocytes that might possibly influence the occurrence of cardio-
vascular incidents like myocardial infarction. No increase in ROS production was 
found in healthy elderly compared to younger individuals.. The increased ROS 
levels and antioxidant status of newborns might influence neonate immunity and 
play a part in cell signalling and development.
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Abbreviations:
ROS  – reactive oxygen species
TPA  – 12-O-tetradecanoyl-phorbol-13-acetate
DHE  – dihydroethidium
DHR  – dihydrorhodamine 123
PFA  – paraformaldehyde
PBS  – phosphate-buffered saline
MFI  – mean fluorescence intensity
TAS  – total antioxidant status
Introduction
Reactive oxygen species (ROS), e.g. superoxide 
anion (O2•-), hydrogen peroxide (H2O2) and hydroxyl 
radical (•OH), are well-known products of metabolism 
in all aerobic cells. ROS constitute an essential part of 
the bactericidal system of phagocytes and function also 
as important mediators of exogenous influences such 
as radiation, UV light, cigarette smoking, fatty acids in 
foods, transition metals, ethanol, pollution, hyperoxia, 
vigorous exercise and ischemia [15, 25]. It has further 
been shown that ROS have many functions in modulat-
ing the activity of intracellular molecules and signalling 
pathways [15, 5, 21, 29]. Moreover, it is also well recog-
nised that ROS in high concentrations have toxic effects 
and mediate oxidative damage to e.g. proteins, lipids 
and DNA and can thus cause cell death, mutations and 
other toxicities [15, 25, 5, 21, 29].
The potential onslaught of oxidants in different 
tissues/organs is normally counterbalanced by a wide 
variety of antioxidants [21, 29]. However, oxidative 
damage results from oxidative stress when an imbal-
ance in the oxidant/antioxidant equilibrium develops, 
either via impairment in the generation of antioxidant 
principles or in association with increased production 
of ROS [29, 26].
Several studies have shown that ROS play a sig-
nificant role in the pathophysiology of cardiovascular 
disease (e.g. atherosclerosis, cardiac ischemia and 
reperfusion damage) [5, 29] and cancer [21]. ROS have 
also been implicated to play a role in diabetes mellitus, 
cataract, Parkinson’s disease, neurodegenerative-, liver-, 
renal- and lung diseases and male infertility [25].
The data supporting the free radical theory of ageing 
is growing. It is hypothesised that the accumulation of 
oxidative damage to mitochondria in differentiated 
cells is a major factor in ageing [28]. Several studies 
indeed show that oxidative damage to mitochondrial 
lipids, proteins and DNA is increasing with age [17, 22, 
30] and that there is an inverse relationship between 
mitochondrial oxidant production and the longevity of 
mammalian species [12, 13].
It is also known that many diseases show diurnal 
variation in onset and outcome, e.g. the increased 
occurrence of cardiovascular incidents such as myo-
cardial infarction, stroke and sudden cardiac death in 
the morning hours after awakening [18, 32]. Given the 
potential role of ROS in the pathogenesis of these disease 
states it has been speculated that circadian variations 
in ROS load may explain the accumulation of events 
in the late night/early morning hours. To support this 
assumption varying levels of oxidative “stress markers” 
like 8-hydroxydeoxyguanosine, malondialdehyde and 
8-isoprostane have been demonstrated in human urine 
during day and night [11].
In this paper we describe two separate studies 
investigating the production and expression of ROS 
in human leukocytes; one study comparing different 
groups of individuals at different ages (span 0–80 years) 
and further one study investigating circadian varia-
tions in leukocyte ROS levels. Both studies recorded 
basal (unstimulated) intracellular ROS levels in both 
monocytes and granulocytes as well as levels after in 
vitro stimulation with the powerful agonist tetradec-
anoyl phorbol acetate (TPA).
Material & Methods
Study populations/blood sampling
Blood samples (anticoagulated with EDTA or hepa-
rin) were taken from healthy, non-smoking individuals. 
All participants were informed about the study and gave 
their written consent for participation. The regional 
ethics committee approved the study. 
To study the influence of age on ROS production in 
leukocytes blood samples were taken from 60 subjects 
sub-divided into five groups; (I) 1–2 days post partum, 
(II) 20 ± 2 years, (III) 40 ± 2 years, (IV) 60 ± 2 years and 
(V) 80 ± 2 years. Each group comprised 12 individuals 
(6 men and 6 women). All samples were taken as fasting 
morning blood samples and kept on ice until further 
preparation within 60 min after collection.
For the study of circadian variation 6 healthy vol-
unteering medical students (3 males and 3 females) 
between 21 and 25 years were followed for 24 hours 
with blood samples taken every 3 hours starting at 9:00 
am. The subjects were offered general hospital meals; 
breakfast between 7 and 9 am, lunch between 11:30 
am and 1 pm, dinner between 4 and 5 pm and a night 
snack between 7 and 8 pm. The subjects were sleeping 
at night, only interrupted by short wake-ups to take 
blood samples.
All subjects were told not to exert physical exercise 
before blood sampling, not to eat vegetables, fruits or 
berries in large quantities and not to take any vitamin 
preparations, dietary supplementations or medications 
of any kind the day before or the same day as blood 
samples were taken.
Reagents
Dihydroethidium (DHE, mainly reflecting superoxide 
anion), dihydrorhodamine 123 (DHR, mainly reflecting 
peroxynitrite and hypochlorous acid), 12-O-tetradec-
anoyl-phorbol-13-acetate (TPA), paraformaldehyde 
(PFA) and phosphate-buffered saline (PBS) tablets were 
all obtained from Sigma, St. Louis, MO, USA.
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Preparation of blood leukocytes for flow cytometry
Ex vivo (basal) levels of ROS in leukocytes were 
measured by immediate postexsanguinational incu-
bation of 50 µl EDTA blood with 5 µmol/L (final 
concentrations) of the ROS-sensitive probes DHE and 
DHR, respectively, for 15 min at 37 °C. After incuba-
tion a hypotonic lysis of erythrocytes was performed 
by adding 30 volumes of lysing solution (156 mmol/L 
NH4Cl, 10 mmol/L NaHCO3, 0.12 mmol/L EDTA) at 
room temperature in the dark for 15 minutes, followed 
by centrifugation at 300 g for 5 minutes at 4 °C. The 
supernatants were discarded and the leukocyte pellet 
was washed once in 2 ml PBS (pH 7.4). Finally, the 
leukocytes were resuspended in 0.5 ml 1% (w/v) PFA 
in PBS and stored in the dark until flow cytometry was 
performed after 1–6 hours.
In vitro (TPA-stimulated) ROS production was 
examined by coincubating 50 µl aliquots of EDTA 
whole blood with TPA (final concentration 100 ng/ml) 
and DHE or DHR (final concentration 5 µmol/L) for 
60 minutes at 37 °C (DHE) or for 90 minutes at 30 °C 
(DHR). At ended incubation the blood was lysed and 
washed as described above for basal samples and finally 
the leukocytes were resuspended in 0.5 ml 1% PFA in 
PBS.
Flow cytometry
The labelled samples were analyzed in a Becton 
Dickinson FACSortTM flow cytometer (Becton Dickin-
son, San Jose, CA, USA) equipped with an argon laser 
and Cell-Quest software (Becton Dickinson). The fluo-
rescense intensity was daily calibrated with Flow-Set 
fluorescent microspheres (Coulter Corporation, Miami, 
FL, USA) according to the manufacturer’s instructions. 
Ten thousand events were collected from each sample 
with light scatter gain set in the linear mode and the 
fluorescence gain set in the logarithmic mode. The 
leukocyte subpopulations, i.e. granulocytes, monocytes 
and lymphocytes, were identified by their light scatter 
characteristics, enclosed in electronic gates and sepa-
rately analyzed for fluorescence intensity (Fig. 1). The 
results are expressed as mean fluorescence intensity 
(MFI). The intra-assay coefficients of variation were < 
1,8% in unstimulated and < 4,7% in TPA-stimulated 
samples.
Total antioxidant status
Total antioxidant status (TAS) was measured in 
heparin plasma using a kit from Randox, Crumlin, UK, 
exactly following the manufacturers instructions. This 
assay is based on the peroxidase-mediated conversion 
of a chromogen to a blue-colored radical cation which 
can be detected at 600 nm. Antioxidants in the added 
plasma sample cause inhibition of this color production 
to a degree that is proportional to their concentration.
Statistics
Data are presented as mean values ± SEM. Age 
groups were compared using the non-parametric 
Mann-Whitney test. Data sets of circadian variation 
were analyzed post hoc using the Wilcoxon paired 
sample test. A p-value of < 0,05 was considered signifi-
cant. All analyses were performed with SPSS 12.0 for 
Windows.
Fig 1: Representative examples of FACSort analyses: The left panel shows a forward/side scatter dot plot with 
gating of blood leukocytes, where the gates R1, R2 and R3 represent granulocytes, monocytes and lymphocytes, 
respectively. The histogram (right panel) illustrates the different DHE fluorescence pattern of unstimulated (open 
histogram) and TPA-stimulated (filled histogram) granulocytes. Horizontal axis: fluorescence intensity, vertical axis: 
cell number.
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Results
Circadian variation
When DHE was used as a probe, 
significant circadian variations in both 
granulocyte and monocyte intracel-
lular ROS levels were recorded. Basal 
(nonstimulated) ROS levels reached its 
lowest values at 3 pm and 12 pm and 
showed significant peaks at 6 pm and 3 
am in both monocytes and granulocytes 
(Fig. 2a). In granulocytes all individuals 
increased their ROSDHE levels at least 
19% (p = 0,027) during the afternoon 
peak and at least 31% (p=0,027) during 
the night/early morning peak. Cor-
responding values for monocytes were 
71% (p = 0,027) and 48% (p = 0,027). 
It should also be noted that basal ROS 
levels were significantly higher at the 
start of the 24 h registration period com-
pared to the end (both 9:00 am). TPA-
stimulated cells increased their ROSDHE 
levels (compared to nonstimulated cells 
incubated for 60 min) on average 66-fold 
and 9-fold (granulocytes and monocytes 
respectively) through the night and day. 
Similar values for ROSDHR were 156-fold 
and 3-fold, respectively. TPA-stimulated 
ROS levels also showed a significant 
peak at 6 pm (p=0,028) and a peak at 
3–6 am (p=0,028) in both monocytes 
and granulocytes (Fig. 2b).
A circadian variation was obtained 
also with DHR as the ROS probe. Basal ROS levels 
showed a significant rise from 12 pm to 3 am in both 
monocytes (p = 0,046) and granulocytes (p= 0,027), 
the ROS levels fading gradually during the day until 
a minimum at 12 pm with no significant peaks at 6 
pm (data not shown). In TPA-stimulated samples (Fig. 
2c) monocytes showed a small ROS increase at 6 pm 
(not significant) and significantly increased levels at 3 
am (p = 0,028) as also shown for DHE. In granulocytes 
a 2,7-fold increased ROS response was observed at 6 
pm compared to 3 pm (p = 0,028), being retained at 
that high level during the whole night, gradually fading 
during the day reaching minimum levels at 3 pm.
The plasma total antioxidant status showed no 
variations and remained stable throughout the day and 
night (Fig. 3).
Age variation
We were not able to demonstrate significant varia-
tions between the four groups of adult people as regards 
either unstimulated (basal) or TPA-stimulated ROS 
levels (Fig. 4). However, the group of newborns differed 
Fig 2: Circadian variation of ROS levels in 
granulocytes (dotted line) and monocytes 
(continuous line). DHE (A and B) and DHR (C) 
were used as probes. Values given are mean 
± SEM (n = 6).  (A) Unstimulated samples 
incubated for 15 min. (B and C) Samples 
stimulated with TPA (100 ng/ml) incubated for 
60 min (B) and 90 min (C).  
*= p≤0,05,  differences vs. preceding minimum 
ROS levels.
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from the other groups in several respects. Compared to 
other age groups there were slightly higher levels of ROS 
in unstimulated monocytes from newborns (p≤0,05) 
(Fig. 4a). In particular, TPA-stimulated monocytes from 
newborns demonstrated intracellular ROS levels which 
far exceeded those of monocytes from any other age 
group (p<0,001) (Fig. 4b). There were also significantly 
higher levels of ROS in the unstimulated granulocytes 
of newborn (p<0,001) (Fig. 4a), whereas the TPA-
stimulated granulocytes (Fig. 4b) did not differ from 
the granulocytes of other age groups as regards ROS 
levels. These observations were the same irrespective 
Fig 3: Plasma TAS levels (mean ± SEM) at different times 
of the day (n= 6).
Fig 4 (left): ROS levels in monocytes and granulocytes 
of the different age groups (newborn (n = 12),  20 ± 
2 years (n = 12),  40 ± 2 years (n = 12),  60 ± 2 years 
(n = 12),  80 ± 2 years (n = 12)) using DHE as probe. 
(A) Unstimulated samples incubated for 60 min. 
(B) Samples stimulated with TPA (100 ng/ml) and 
incubated for 60 min. (* = p≤0,05, *** = p<0,001, 
difference vs. all other age groups)
Fig 5: Plasma TAS levels (mean ± SEM) in the different age 
groups. (*** = p<0,001, difference vs. all other age groups)
450 Neuroendocrinology Letters Vol.27 No.4, 2006 • Copyright © Neuroendocrinology Letters ISSN 0172–780X  www.nel.edu
Kristian Stritesky Larssen & Torstein Lyberg
of whether DHE or DHR (data not shown) were used 
as a probe. The plasma total antioxidant capacity of 
newborns was also significantly higher (p<0,001) and 
differed from all other age groups (Fig. 5).
There were no significant differences between males 
and females within the groups and for the statistical 
analysis we chose to treat them as one group.
Discussion
In this study we demonstrated a circadian variation 
of ROS levels in leukocytes of young male and female 
individuals. This variation was most prominent when 
DHE was used as a probe. Both in unstimulated leuko-
cytes (granulocytes and monocytes) and in leukocytes 
stimulated with the powerful ROS inducer TPA we 
demonstrated two peaks of ROS activity, one in the 
late afternoon and another in the night/early morning 
hours. However, in the case of DHR monitoring these 
two peaks were replaced by a more prolonged increased 
TPA response during night time. We also observed that 
the basal leukocyte and stimulated monocyte ROSDHE 
levels registered at 9 am at the start of the observation 
period were significantly higher than those at 9 am the 
second morning. This difference probably reflects the 
fact that the participants the first morning had to exert 
some physical activity to get to the laboratory in due 
time. In contrast, all participants had a quiescent start 
of the day the second morning, waking up in the hotel 
premises of this hospital where the blood samples also 
were taken. It is well established that physical exercise 
has an inducer effect on neutrophil ROS production 
[20], and it is probable that even light physical activ-
ity following a whole night of inactivity may add to 
or potentiate the morning peak of the diurnal ROS 
rhythm. Altogether, our findings demonstrate the fact 
that the specificity of the two fluorescent probes used 
(and others as well) is not known in detail, thus causing 
some difficulties in the interpretation of data. However, 
both probes used for ROS detection showed a seem-
ingly consistent pattern of diurnal ROS variation. 
We speculate that varying levels of ROS might 
contribute to higher risk of some disease incidents at 
certain times of the day/night. Cardiovascular events 
like myocardial infarction and sudden cardiac death 
are known to follow a circadian pattern with a peak of 
increased risk in the morning hours and a smaller peak 
in the afternoon [18, 32]. The high incidence of acute 
cardiovascular events in the morning after awakening 
and arising has been ascribed to the surge of heart 
rate and blood pressure due to sympathetic activation 
[18, 19] as well as other neural or humoral vasoactive 
factors and changes in hemostatic activity. However, 
myocardial infarction during night (sleep) has been 
thought to have a different pathogenesis and not be 
related to sympathetic activation or triggering events 
[18]. Based on our present findings it is possible that 
the increased leukocyte ROS in the night/early morning 
might contribute to cardiovascular events by represent-
ing an additional internal trigger of pathophysiological 
effects. The observation mentioned above that activity 
in the morning after arising may supervene on the 
diurnal ROS peak further strengthens this assumption. 
Oxidative stress is also believed to initiate a prothrom-
botic state [6, 14] and vasoconstriction [31] that adds 
to the increase in platelet aggregability on assuming the 
upright posture and the final trough of the fibrinolytic 
system [19].
We are not aware of earlier studies investigating the 
circadian variations of ROS production in intact human 
cells. The mechanisms of this variation are unknown. 
However, oxidative stress markers like 8-hydroxyde-
oxyguanosine, malondialdehyde and 8-isoprostane 
have been demonstrated in urine with a typical diurnal 
variation, all markers peaking in the afternoon at about 
6–8 pm [11]. Theoretically, this peak of oxidative mark-
ers in urine might be a delayed reflection of oxidative 
damage taking place as a result of the late night/early 
morning peak of ROS in blood. The circadian variation 
of ROS levels could also be influenced by concentra-
tions of antioxidant principles. For instance, melatonin 
levels increase during dark and peak at 3–4 am [7]. The 
antioxidant effect of melatonin might thus oppose the 
effect of ROS production during the night.
As reviewed briefly in the introduction oxidative 
damage also plays a major role in ageing. Some studies 
have shown increased oxidant production in rat hepa-
tocytes [9, 27] and human granulocytes [16] as well as 
increased volatile organic breath markers of oxidative 
stress [23] with age. However, other studies have shown 
impairment of the oxidative burst with age [3, 24]. 
This might reflect a complex interaction between ROS 
production and ageing and that ageing can influence 
different transductional pathways in different ways [3]. 
Oxidative stress and damage play an important role in 
ageing, but on the other hand the significant decrease in 
the microbiocidal capacity of the polymorphonuclear 
cells with age is partly attributed to a decrease in ROS 
production [24].
In the present study we were not able to identify any 
increase or decrease of ROS production in leukocytes 
dependent on age, the only exception being newborns, 
vide infra. Likewise, the total antioxidant capacity of 
plasma did not differ between adults of all ages. This 
may reflect the fact that only healthy individuals were 
recruited to the study and that good health, despite 
old age, is characterized by a maintained oxidant/
antioxidant balance. Derangement of the equilibrium 
between pro- and antioxidant principles is obviously 
a prerequisite for disease to progress and it is presum-
ably a gradual wear-out of antioxidant mechanisms 
that eventually promotes ageing and also precipitates 
the variety of diseases associated with oxidative stress. 
The lack of difference in ROS production between the 
different age groups of adults could also indicate that 
the increasing oxidative stress in ageing is a result of 
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accumulation of oxidative damage over time, rather 
than increased oxidant production per se.
Few of the previous studies have included newborn 
babies as an age group. In the present study we found 
significantly increased TPA-stimulated ROS levels in 
newborn monocytes and increase of basal ROS levels in 
both granulocytes and monocytes of the newborn. This 
increased ROS generation capacity of newborns was, 
however, counterbalanced by a significantly increased 
total antioxidant capacity in plasma. This corresponds 
with previous studies that have shown an increased 
respiratory burst [8] and increased superoxide anion 
production (but decreased hydroxyl radical produc-
tion) [1, 4] in neonate neutrophils compared with adult. 
A study of Phillips et al. [23] also showed increased 
oxidative stress in younger as well as in older humans. 
An increased leukocyte capacity for ROS production 
may have an impact on the function of the newborn 
immune system and its susceptibility to infections. It is 
also possible that this is a normal physiological response 
in childhood/youth as there is increasing evidence that 
ROS act as signal transducers during normal growth 
and development [23].
We also found significantly increased plasma total 
antioxidant capacity in the group of newborns com-
pared to all other age groups. However, previous studies 
have shown that newborns, though especially preterm 
babies, have a limited antioxidant protective capac-
ity [10] and lower levels of the antioxidant vitamins 
E and A in infant cord blood compared to maternal 
blood [2]. We do not know the cause of this apparent 
discrepancy.
We conclude that there is a circadian variation of 
ROS expression in human leukocytes and that this 
might possibly influence the risk of cardiovascular 
disease incidents like myocardial infarction. We further 
demonstrated higher levels of ROS in leukocytes of 
newborns than in any other age group which might 
have implications for innate immunity and infection 
resistance. On the other hand, ROS in leukocytes and 
antioxidant capacity in plasma seemed to be at the 
same levels in all other age groups. This indicates that 
good health is associated with a balanced oxidant/anti-
oxidant ratio independent of high age.
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